Please Wait...

Cardiac Safety

World-renowned scientific expertise, regulatory leadership and integrated technology for high quality centralized cardiac safety trials.

Cardiovascular Safety Services from Bioclinica

With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership. Bioclinica's medical and scientific team, consisting of board-certified cardiologists and active members of the Cardiac Safety Research Consortium, has strong experience in successfully designing and supporting studies that require cardiac safety monitoring. Our focus goes beyond the single study and across the entire cardiac safety profile of the study compound from Phase I–IV. With experience working alongside the ICH, FDA, EMA, PMDA, and SFDA in the development of regulatory and industry guidelines, Bioclinica is the smart choice to support the design and conduct of cardiac safety studies around the globe.

ECG MEASUREMENTS

Manual and automated ECG analysis and Digital Holter analysis.
LEARN MORE

THOROUGH QT STUDIES

Innovative and conventional TQT study design and support.
LEARN MORE

BLOOD PRESSURE

Ambulatory and Automated Blood Pressure and Pulse Wave Analysis.
LEARN MORE

CARDIOVASCULAR IMAGING

Cardiac safety endpoints using a range of imaging modalities.
LEARN MORE

PROTOCOL DESIGN AND EXPERT REPORTING

Study design and Consultative Services.
LEARN MORE

WEBHEART PLATFORM

Robust, validated trial management tool.
LEARN MORE

SCIENTIFIC & REGULATORY EXPERTISE

30+ years of proven strategic expertise.
LEARN MORE

COLLATERAL

Learn more & eBrochures.
LEARN MORE

 

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Hope to see you at DIA's #Pharmacovigilance & Risk Mgmt Strategies Conf. this wk! Visit @Bioclinica in booth 32. Pr… https://t.co/nzEzlJcoL0
bioclinica (17 hours ago)
RT @ConferenceForum: Honored to have @bioclinica as an associate sponsor of 2018 #IO360nyc: https://t.co/ZXdgZTMDqc https://t.co/27mfxg65aT
bioclinica (18 hours ago)
RT @bioclinica: Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinical suppl…
bioclinica (18 hours ago)
ASCPT 2018 Annual Meeting https://t.co/i0mjYbBq5N Join @Bioclinica Research's Open House 3/22 https://t.co/citlLotbD7
bioclinica (4 days ago)
Heading to DC for DIA's #Pharmacovigilance & Risk Mgmt Strategies Conf.? Visit @Bioclinica in booth 32. Preview our… https://t.co/alU1sCg04l
bioclinica (4 days ago)
Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinic… https://t.co/rXBGvIh9Wr
bioclinica (5 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen